These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11425972)
1. Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG--preliminary study. Inoue T; Koyama K; Oriuchi N; Alyafei S; Yuan Z; Suzuki H; Takeuchi K; Tomaru Y; Tomiyoshi K; Aoki J; Endo K Radiology; 2001 Jul; 220(1):54-62. PubMed ID: 11425972 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205 [TBL] [Abstract][Full Text] [Related]
3. Schwannoma of the extremities: the role of PET in preoperative planning. Ahmed AR; Watanabe H; Aoki J; Shinozaki T; Takagishi K Eur J Nucl Med; 2001 Oct; 28(10):1541-51. PubMed ID: 11685498 [TBL] [Abstract][Full Text] [Related]
4. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET. Watanabe H; Inoue T; Shinozaki T; Yanagawa T; Ahmed AR; Tomiyoshi K; Oriuchi N; Tokunaga M; Aoki J; Endo K; Takagishi K Eur J Nucl Med; 2000 Oct; 27(10):1509-17. PubMed ID: 11083540 [TBL] [Abstract][Full Text] [Related]
5. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230 [TBL] [Abstract][Full Text] [Related]
6. 18F alpha-methyl tyrosine PET studies in patients with brain tumors. Inoue T; Shibasaki T; Oriuchi N; Aoyagi K; Tomiyoshi K; Amano S; Mikuni M; Ida I; Aoki J; Endo K J Nucl Med; 1999 Mar; 40(3):399-405. PubMed ID: 10086702 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET. Miyakubo M; Oriuchi N; Tsushima Y; Higuchi T; Koyama K; Arai K; Paudyal B; Iida Y; Hanaoka H; Ishikita T; Nakasone Y; Negishi A; Mogi K; Endo K Ann Nucl Med; 2007 Feb; 21(2):129-35. PubMed ID: 17424980 [TBL] [Abstract][Full Text] [Related]
8. Assessment of therapy response in lung cancer with ¹⁸F-α-methyl tyrosine PET. Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Mori M; Endo K AJR Am J Roentgenol; 2010 Nov; 195(5):1204-11. PubMed ID: 20966329 [TBL] [Abstract][Full Text] [Related]
9. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG. Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287 [TBL] [Abstract][Full Text] [Related]
11. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719 [TBL] [Abstract][Full Text] [Related]
12. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196 [TBL] [Abstract][Full Text] [Related]
13. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536 [TBL] [Abstract][Full Text] [Related]
14. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149 [TBL] [Abstract][Full Text] [Related]
15. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Martin WH; Delbeke D; Patton JA; Sandler MP Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: a clinicopathological study. Kaira K; Oriuchi N; Shimizu K; Ishikita T; Higuchi T; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Endo K; Mori M Int J Cancer; 2009 Mar; 124(5):1152-60. PubMed ID: 19065657 [TBL] [Abstract][Full Text] [Related]
17. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033 [TBL] [Abstract][Full Text] [Related]
18. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent. Inoue T; Tomiyoshi K; Higuichi T; Ahmed K; Sarwar M; Aoyagi K; Amano S; Alyafei S; Zhang H; Endo K J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678 [TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]